Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Other Accumulated Expenses (2021 - 2025)

BioScience Health Innovations (BHIC) has disclosed Other Accumulated Expenses for 5 consecutive years, with $228298.0 as the latest value for Q3 2025.

  • Quarterly Other Accumulated Expenses rose 559.82% to $228298.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $228298.0 through Sep 2025, up 559.82% year-over-year, with the annual reading at $87074.0 for FY2023, 91.98% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $228298.0 at BioScience Health Innovations, up from $47837.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $228298.0 in Q3 2025, with the low at $404.0 in Q1 2022.
  • Average Other Accumulated Expenses over 5 years is $65806.8, with a median of $46777.5 recorded in 2025.
  • The sharpest move saw Other Accumulated Expenses tumbled 86.68% in 2024, then skyrocketed 559.82% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $625.0 in 2021, then crashed by 35.36% to $404.0 in 2022, then skyrocketed by 21452.97% to $87074.0 in 2023, then crashed by 60.26% to $34600.0 in 2024, then surged by 559.82% to $228298.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $228298.0, $47837.0, and $45718.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.